Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ãùúÐîÜ ñòãÖàõ ÊÜÌ¿ï½°ú ÊÜËÝÓÞá¬øà úÞßÚ°úÀÇ ßÓμμÌõ¿¡ μÇÑ æÚϼ Experimental Studies on Relationship between Hyperplastic Hepatic Nodule and Hepatic Megalocytosis of the Liver

´ëÇѺ´¸®ÇÐȸÁö 1973³â 7±Ç 2È£ p.103 ~ 109
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¾¸¸(ÐÝñ£Ø¿)/Chong Man Kim ±è¿ëÀÏ(ÐÝé¸ìé)/ÀÌÁ¦±¸(ì°ð­Îú)/Yong Il Kim/Chae Koo Lee

Abstract


Experimental induction of hyperplastic hepatic nodules was carried out by administra-
tion of p-dimethylaminoazobenzene in rats, to correlate with hepatic megalocytosis and
to clarify sequence of precancerous lesion.
Hyperplastic hepatic nodules and megalocytosis were induced in most of rats following
administration of p-DAB : megalocytosis developed during the initial phase (before the
12th wk) of carcinogenesis, and showed a tendency to spread panlobularly from
periportal distribution. Those paralleled with increase of compensatory mitotic index
following hepatic cell damages by ingestion of p-DAB. Megalocytic index diminished
during the phase of hyperplastic nodules and hepatocellular carcinomas, and illustrated
no direct relationship with carcinogenesis.
Number of hyperplastic nodules regressed with prolongation of experimental duration
after cessation of administrating p-DAB.
There was a strong evidence to indicate that megalocytosis and compensatory
proliferation of hepatocytes would preceed in the p-DAB induced hepatic carcinogenesis
and the latter only undergoes into precancerous phase of hyperplastic hepatic nodule.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS